European LeukemiaNet 2022 Risk Stratification

**Semantic type:** Intellectual Product

**Definition:** A risk stratification for acute myeloid leukemia based on cytogenetic aberrations and selected gene mutations. It was proposed in 2010 and updated in 2017 and 2022 with new aberrations and genes. Risk categories are favorable, intermediate, and adverse.

**Synonyms:** - ELN 2022 Risk - ELN 2022 Risk Stratification - ELN22 - European LeukemiaNet (ELN) 2022 risk stratification